RecruitingNCT06055010

Improving Pancreatic Cancer Care by the Use of Computational Science and Technology

Sponsor

UMC Utrecht

Enrollment

5,000 participants

Start Date

Jan 1, 2014

Study Type

OBSERVATIONAL

Conditions

Pancreatic Cancer Pancreatic Adenocarcinoma Pancreas Adenocarcinoma Pancreatic Cyst Pancreas Cyst Pancreatic Diseases

Summary

The goal of the IMPACT project is to set up a data sharing infrastructure between expert centers for pancreatic surgery that enables training, testing and validation of computer science tools to improve quality of care for patients with pancreatic cancer.

Eligibility

Plain Language Summary

Simplified for easier understanding

This study is using advanced computer technology and artificial intelligence to analyze data from pancreatic cancer patients, with the goal of improving how this cancer is diagnosed and treated. **You may be eligible if...** - You are 18 years or older - You have received diagnostic procedures or treatment for a benign or malignant pancreatic lesion and are registered in the Dutch Pancreatic Cancer Project (PACAP) database - OR you are a healthy individual who has had an abdominal CT scan (as a control participant) **You may NOT be eligible if...** - You object to having your medical data used for scientific research purposes Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo interventions

Considering the retrospective nature of this project and use of existing clinical and technical data, this project contains no interventions or prospective inclusion of healthy subjects / patients for the execution of experiments.

Locations(1)

Regional Academic Cancer Center Utrecht

Utrecht, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06055010

Related Trials

DESTINY-PANTUMOUR04

NCT0712400017 locations

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

NCT0725223217 locations

In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers

NCT072063551 location

Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery

NCT054283583 locations

Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers

NCT028388361 location